Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:bcr06.2008.0127.
doi: 10.1136/bcr.06.2008.0127. Epub 2009 Apr 7.

Malignant neurilemoma with xeroderma pigmentosum

Affiliations

Malignant neurilemoma with xeroderma pigmentosum

Li Na Wang et al. BMJ Case Rep. 2009.

Abstract

Xeroderma pigmentosum is a rare autosomal recessive disease characterised by hypersensitivity to sunlight, and is associated with a high incidence of skin cancer. We report a case of xeroderma pigmentosum with malignant neurilemoma in a 46-year-old woman which is unique due to its presentation, which was confirmed histopathologically.

Trial registration number: 31095.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The patient with a mass in the left orbit preoperatively. The pigmented lesion was raised 4–6 mm from the surface. She developed a firm mass in the interpalpebral zone of the left eye measuring 2.0×2.5 cm, which was attached to the palpebral conjunctiva and the eyelids.
Figure 2
Figure 2
Magnetic resonance image disclosing a heterogeneous signal intensity on T2 weighted images.
Figure 3
Figure 3
Histological examination revealed a typical pattern of schwannoma consisting of Antoni type B. Histopathologically, the tumour tissue consists of so-called Antoni A and B type cells. Type A tissue shows densely packed, elongated spindle cells, while type B tissue has a more myxoid consistency. Haematoxylin and eosin; original magnification ×20.
Figure 4
Figure 4
S-100 protein is positive in immunochemistry staining. Immunohistochemically, the tumour cells were partly positive for S-100. Original magnification ×200.
Figure 5
Figure 5
The mass in the left orbit was dissected 2 weeks postoperatively.

Similar articles

Cited by

  • Xeroderma pigmentosum: an updated review.
    Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Leung AK, et al. Drugs Context. 2022 Apr 25;11:2022-2-5. doi: 10.7573/dic.2022-2-5. eCollection 2022. Drugs Context. 2022. PMID: 35520754 Free PMC article. Review.

References

    1. Norgauer J, Idzko M, Panther E, et al. Xeroderma pigmentosum. Eur J Dermatol 2003; 13: 4–9 - PubMed
    1. Hebra F, Kaposi M. On diseases of the skin including exanthemata. New Sydenham Soc 1874; 61: 252–8
    1. Mseddi M, Sellami D, Elloumi Y, et al. Ophthalmologic manifestations of the xeroderma pigmentosum. Tunis Med 2006; 84: 542–4 - PubMed
    1. Yamashiro S, Nagahiro S, Mimata C, et al. Malignant trigeminal schwannoma associated with xeroderma pigmentosum—case report. Neurol Med Chir (Tokyo) 1994; 34: 817–20 - PubMed
    1. Nakamura T, Ono T, Yoshimura K, et al. Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D. J Am Acad Dermatol 1991; 25(2pt 2): 349–53 - PubMed

LinkOut - more resources